Rayscape Raises €263.6K Seed Round to Expand AI Radiology Platform

Rayscape Secures €263.6K Seed Funding

Rayscape, a Romanian med-tech company, has raised a €263,600 seed round. The funding was backed by Growceanu and Bravva Angels. No lead investor was disclosed for the round.

What Rayscape Does

Founded in 2018, Rayscape builds AI software that helps radiologists analyze X-ray and CT images faster and more accurately. The company was originally known as XVision and emerged from the Mindfully Technologies team at Politehnica University of Timisoara.

Its oncology-focused imaging platform is used in more than 300 clinical locations across 18 countries, according to the company.

Funding Details

• Round type: Seed
• Amount: €263,600
• Investors: Growceanu, Bravva Angels
• Lead investor: Not disclosed
• Announcement date: October 22, 2026

Strategic Context

The raise gives Rayscape additional capital as it continues to develop and distribute its AI-assisted radiology tools. The company's stated focus on oncology imaging and its existing footprint of more than 300 clinical locations across 18 countries position it in the clinical decision-support segment of medical imaging.

For acquisition-oriented observers, the seed round represents an early-stage financing event for a med-tech software company with an established user base in multiple markets. The participation of Growceanu and Bravva Angels provides the investor base for this round; no lead investor was named in the disclosed details.